Mochi Health has a Better Business Bureau (BBB) customer review rating of 1.32 out of 5 stars. Most complaints were related ...

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature ...

We worked with testers, whose identities we have verified, to test the products and services mentioned in this story. Due to ...

In recent years, weight-loss drugs have become a common addition to diet and exercise routines. The rise of GLP-1 medications ...

Adults who lost weight with once-weekly injectable semaglutide or tirzepatide were able to maintain more than 70% of their ...

Permission to take things down a step. Getting your steps in every day is great for health and has been shown to improve ...

Chevonne Black, a 38‑year‑old mother, turned to Piedmont Medical Center for bariatric surgery after knee problems and ...

Super producer DJ Khaled has a lot to smile about these days, showing off a dramatic weight loss that has his fans shook!

Two phase 3b trials evaluated the efficacy and safety of tirzepatide or orforglipron for weight maintenance after injectable incretin treatment.

GLP‑1 and next‑generation obesity drugs are gaining traction across the U.S. and globally, which is good news for investors.